• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于新木脂素 veraguensin、grandisin 和 machilin G 的 3,5-二芳基异恶唑类似物的设计、合成及抗利什曼原虫活性。

Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G.

机构信息

LASQUIM - Laboratório de Síntese e Química Medicinal, FACFAN - Faculdade de Ciências Farmacêuticas, Alimentos e Nutrição, Universidade Federal do Mato Grosso do Sul, UFMS, Campo Grande, MS, Brazil.

Laboratorio de Parasitologia Humana, INBIO - Instituto de Biologia, Universidade Federal do Mato Grosso do Sul, Campo Grande, MS, Brazil.

出版信息

Chem Biol Drug Des. 2019 Mar;93(3):313-324. doi: 10.1111/cbdd.13417. Epub 2018 Nov 25.

DOI:10.1111/cbdd.13417
PMID:30354012
Abstract

Using bioisosterism as a medicinal chemistry tool, 16 3,5-diaryl-isoxazole analogues of the tetrahydrofuran neolignans veraguensin, grandisin and machilin G were synthesized via 1,3-dipolar cycloaddition reactions, with yields from 43% to 90%. Antitrypanosomatid activities were evaluated against Trypanosoma cruzi, Leishmania (L.) amazonensis and Leishmania (V.) braziliensis. All compounds were selective for the Leishmania genus and inactive against T. cruzi. Isoxazole analogues showed a standard activity on both promastigotes of L. amazonensis and L. braziliensis. The most active compounds were 15, 16 and 19 with IC values of 2.0, 3.3 and 9.5 μM against L. amazonensis and IC values of 1.2, 2.1 and 6.4 μM on L. braziliensis, respectively. All compounds were noncytotoxic, showing lower cytotoxicity (>250 μM) than pentamidine (78.9 μM). Regarding the structure-activity relationship (SAR), the methylenedioxy group was essential to antileishmanial activity against promastigotes. Replacement of the tetrahydrofuran nucleus by an isoxazole core improved the antileishmanial activity.

摘要

利用生物等排作为药物化学工具,通过 1,3-偶极环加成反应合成了 16 个 3,5-二芳基异恶唑类似物,包括四氢呋喃新木脂素 veraguensin、grandisin 和 machilin G,产率为 43%至 90%。对 Trypanosoma cruzi、Leishmania (L.) amazonensis 和 Leishmania (V.) braziliensis 进行了抗锥虫生物活性评估。所有化合物均对利什曼原虫属具有选择性,对 T. cruzi 无活性。异恶唑类似物对 L. amazonensis 和 L. braziliensis 的前鞭毛体均表现出标准活性。最活跃的化合物是 15、16 和 19,对 L. amazonensis 的 IC 值分别为 2.0、3.3 和 9.5 μM,对 L. braziliensis 的 IC 值分别为 1.2、2.1 和 6.4 μM。所有化合物均无细胞毒性,其细胞毒性(>250 μM)低于戊脒(78.9 μM)。关于构效关系(SAR),亚甲二氧基基团对前鞭毛体的抗利什曼原虫活性至关重要。用异恶唑核取代四氢呋喃核可提高抗利什曼原虫活性。

相似文献

1
Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G.基于新木脂素 veraguensin、grandisin 和 machilin G 的 3,5-二芳基异恶唑类似物的设计、合成及抗利什曼原虫活性。
Chem Biol Drug Des. 2019 Mar;93(3):313-324. doi: 10.1111/cbdd.13417. Epub 2018 Nov 25.
2
Effect of isoxazole derivatives of tetrahydrofuran neolignans on intracellular amastigotes of Leishmania (Leishmania) amazonensis: A structure-activity relationship comparative study with triazole-neolignan-based compounds.四氢呋喃新木脂素异恶唑衍生物对美洲钩端螺旋体(利什曼原虫)内阿米巴的影响:与三唑新木脂素类化合物的构效关系比较研究。
Chem Biol Drug Des. 2019 Dec;94(6):2004-2012. doi: 10.1111/cbdd.13609. Epub 2019 Sep 12.
3
Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.针对克氏锥虫和亚马逊利什曼原虫具有活性的一系列新型3,5-二取代异恶唑的设计与合成。
Eur J Med Chem. 2017 Mar 10;128:25-35. doi: 10.1016/j.ejmech.2017.01.029. Epub 2017 Jan 23.
4
Antileishmanial Activity and Structure-Activity Relationship of Triazolic Compounds Derived from the Neolignans Grandisin, Veraguensin, and Machilin G.源自新木脂素grandisin、veraguensin和machilin G的三唑类化合物的抗利什曼原虫活性及构效关系
Molecules. 2016 Jun 20;21(6):802. doi: 10.3390/molecules21060802.
5
Synthesis and SAR of new isoxazole-triazole bis-heterocyclic compounds as analogues of natural lignans with antiparasitic activity.新型异噁唑-三唑双杂环化合物的合成及构效关系研究,此类化合物为具有抗寄生虫活性的天然木脂素类似物。
Bioorg Med Chem. 2018 Sep 15;26(17):4850-4862. doi: 10.1016/j.bmc.2018.08.025. Epub 2018 Aug 19.
6
Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5-disubstituted isoxazole compounds based on 5-nitrofuran scaffolds.基于 5-硝基呋喃骨架的新型 3,5-二取代异恶唑化合物的设计、合成、抗利什曼原虫和抗真菌生物评价。
Arch Pharm (Weinheim). 2020 Feb;353(2):e1900241. doi: 10.1002/ardp.201900241. Epub 2019 Dec 16.
7
Synthesis and 2D-QSAR studies of neolignan-based diaryl-tetrahydrofuran and -furan analogues with remarkable activity against Trypanosoma cruzi and assessment of the trypanothione reductase activity.基于新木脂素的二芳基四氢呋喃和呋喃类似物的合成及二维定量构效关系研究,这些类似物对克氏锥虫具有显著活性,并对锥虫硫醇还原酶活性进行评估。
Eur J Med Chem. 2017 Nov 10;140:187-199. doi: 10.1016/j.ejmech.2017.08.064. Epub 2017 Sep 4.
8
In Vivo Antileishmanial Effect of 3,5-Diaryl-isoxazole Analogues Based on Veraguensin, Grandisin, and Machilin G: A Glance at a Preclinical Study.基于威拉固素、大根香叶烯 D 和麻竹素 G 的 3,5-二芳基异恶唑类似物的体内抗利什曼原虫作用:一项临床前研究概述。
ACS Infect Dis. 2023 May 12;9(5):1150-1159. doi: 10.1021/acsinfecdis.3c00090. Epub 2023 Apr 27.
9
Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents.新型 2,3-取代喹喔啉衍生物的合成及抗利什曼原虫和抗锥虫活性评价。
Eur J Med Chem. 2015 Jan 27;90:107-23. doi: 10.1016/j.ejmech.2014.11.018. Epub 2014 Nov 11.
10
Design, synthesis and antitrypanosomatid activity of 2-nitroimidazole-3,5-disubstituted isoxazole compounds based on benznidazole.基于苯并硝唑的 2-硝基咪唑-3,5-二取代异恶唑化合物的设计、合成及抗锥虫活性。
Eur J Med Chem. 2023 Nov 15;260:115451. doi: 10.1016/j.ejmech.2023.115451. Epub 2023 May 5.

引用本文的文献

1
Antileishmanial Activity, Toxicity and Mechanism of Action of Complexes of Sodium Usnate with Lanthanide Ions: Eu(III), Sm(III), Gd(III), Nd(III), La(III) and Tb(III).没那酸盐与镧系离子(Eu(III)、Sm(III)、Gd(III)、Nd(III)、La(III)和 Tb(III))配合物的抗利什曼原虫活性、毒性和作用机制。
Int J Mol Sci. 2023 Dec 28;25(1):413. doi: 10.3390/ijms25010413.
2
Drug Discovery for Cutaneous Leishmaniasis: A Review of Developments in the Past 15 Years.皮肤利什曼病的药物研发:过去15年进展综述
Microorganisms. 2023 Nov 23;11(12):2845. doi: 10.3390/microorganisms11122845.
3
Isoxazole/Isoxazoline Skeleton in the Structural Modification of Natural Products: A Review.
天然产物结构修饰中的异恶唑/异恶唑啉骨架:综述
Pharmaceuticals (Basel). 2023 Feb 2;16(2):228. doi: 10.3390/ph16020228.
4
Flavonoid Derivatives as New Potent Inhibitors of Cysteine Proteases: An Important Step toward the Design of New Compounds for the Treatment of Leishmaniasis.黄酮类衍生物作为新型强效半胱氨酸蛋白酶抑制剂:迈向设计治疗利什曼病新化合物的重要一步。
Microorganisms. 2023 Jan 16;11(1):225. doi: 10.3390/microorganisms11010225.
5
Synthesis and Antiprotozoal Profile of 3,4,5-Trisubstituted Isoxazoles.3,4,5-三取代异恶唑的合成及抗原虫活性。
ChemistryOpen. 2021 Oct;10(10):931-938. doi: 10.1002/open.202100141. Epub 2021 Jul 30.
6
Antileishmanial assessment of isoxazole derivatives against .异恶唑衍生物对利什曼原虫的抗利什曼原虫评估 。 你提供的原文似乎不完整,“against”后面缺少具体内容。
RSC Med Chem. 2020 Jul 20;11(9):1053-1062. doi: 10.1039/d0md00083c. eCollection 2020 Sep 1.
7
A Triazole Hybrid of Neolignans as a Potential Antileishmanial Agent by Triggering Mitochondrial Dysfunction.三唑杂新木脂素类化合物通过触发线粒体功能障碍发挥抗利什曼原虫作用
Molecules. 2019 Dec 20;25(1):37. doi: 10.3390/molecules25010037.